Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Pfizer officer Jennifer B. Damico sold about $51K of company shares
Traded Jun 9, 2026 · Filed Jun 10, 2026
- ~$51K
- Reported value · 2,000 sh @ $25.70
- 31K
- Holds after · shares reported
- +9.4%
- stock since the trade · S&P 500 +3.7%, $25.70 → $28.12 on Oct 1
Why it stands out
Pfizer's SVP & Controller sold $51K of Pfizer shares. Nobody planned it ahead of time.
- No pre-arranged plan is mentioned in the filing
- Sold 6% of their holdings
- Their first sale in the data covering the past year
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 10, 2026
Officer$25K–$100K
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$51,400
Shares × reported transaction price
- Timing vs results
35 days after results of May 5, 2026, 56 days before results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Price at the time
